We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 5 of 21
Most popular |Most recent

Patent and Pharma Update - October 2018

United Kingdom, Bulgaria, European Union - October 11 2018 In our last Patent and Pharma update, we reported on the opinion of Advocate General Wathelet (the “AG”) on the interpretation of Article 3(a) of the...

Krishna Kakkaiyadi, Rachel Montagnon.

EPO publishes 2018 revision of Guidelines for Examination directed to computer-implemented inventions

European Union - October 10 2018 The EPO has recently published the 2018 revision to its Guidelines for Examination, which are generally updated annually to take into account...

Krishna Kakkaiyadi, Julie Chiu.

UK Government launches consultation on role of MHRA post-Brexit and confirms commitment to underwrite Horizon 2020 funding

United Kingdom - October 4 2018 The UK Government has today launched a consultation on the role of the Medicines and Healthcare products Regulatory Agency (MHRA) post-Brexit “seeking...

Rachel Montagnon.

Patent and Pharma Update

United Kingdom, European Union - July 10 2018 Since Actavis v Lilly transformed the UK’s approach to patent infringement, there have been only a handful of cases which have grappled with the new...

Krishna Kakkaiyadi, Monika Klajn, Rachel Montagnon.

The English Court Grants Carve-Out Preliminary Injunction Where No Alternative Treatment Available

United Kingdom - June 7 2018 Arnold J’s judgment in Edwards Lifesciences LLC v Boston Scientific SCIMED, Inc and others 2018 EWHC 1256 (Pat) handed down on 24 May 2018...

Monika Klajn.